• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锌和铜与阿尔茨海默病淀粉样β肽结合的分子模拟

Molecular modeling of zinc and copper binding with Alzheimer's amyloid beta-peptide.

作者信息

Han Daxiong, Wang Haiyan, Yang Pin

机构信息

Department of Pharmacy, Medical College of Xiamen University, Xiamen, China.

出版信息

Biometals. 2008 Apr;21(2):189-96. doi: 10.1007/s10534-007-9107-6. Epub 2007 Jul 13.

DOI:10.1007/s10534-007-9107-6
PMID:17629774
Abstract

Aggregation of the amyloid beta-peptide (Abeta) into insoluble fibrils is a key pathological event in Alzheimer's disease. Cu(II) and Zn(II) ions were reported to be able to induce Abeta aggregation at nearly physiological concentrations in vitro. In this study, the binding modes of Cu(II) and Zn(II) in this process were explored by molecular modeling. In the pre-associated Abeta, Ntau atom of imidazole ring of His14, O atom of carbonyl of main-chain and two O atoms of water occupied the four ligand positions of the complex. While in the aggregated form of Abeta, the His13(N)-Metals-His14(N) bridges were formed through metal cross-linking action. These results would be helpful to put insight on revealing the formation mechanism of pathogenic Abeta aggregates in brain.

摘要

淀粉样β肽(Aβ)聚集成不溶性纤维是阿尔茨海默病的关键病理事件。据报道,铜(II)和锌(II)离子在体外接近生理浓度时能够诱导Aβ聚集。在本研究中,通过分子模拟探索了铜(II)和锌(II)在此过程中的结合模式。在预结合的Aβ中,His14咪唑环的Ntau原子、主链羰基的O原子和两个水分子的O原子占据了配合物的四个配体位置。而在Aβ的聚集形式中,通过金属交联作用形成了His13(N)-金属-His14(N)桥。这些结果将有助于深入了解大脑中致病性Aβ聚集体的形成机制。

相似文献

1
Molecular modeling of zinc and copper binding with Alzheimer's amyloid beta-peptide.锌和铜与阿尔茨海默病淀粉样β肽结合的分子模拟
Biometals. 2008 Apr;21(2):189-96. doi: 10.1007/s10534-007-9107-6. Epub 2007 Jul 13.
2
Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide.与β-淀粉样肽配位的铜离子和锌离子的生物无机化学
Dalton Trans. 2009 Feb 21(7):1080-94. doi: 10.1039/b813398k. Epub 2008 Nov 26.
3
Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.锌(II)和铜(II)与全长阿尔茨海默病淀粉样β肽的结合。
J Neurochem. 2008 Mar;104(5):1249-59. doi: 10.1111/j.1471-4159.2007.05061.x.
4
Inhibitory effect of copper(II) on zinc(II)-induced aggregation of amyloid beta-peptide.铜(II)对锌(II)诱导的淀粉样β肽聚集的抑制作用。
Biochem Biophys Res Commun. 2001 Jul 27;285(4):991-6. doi: 10.1006/bbrc.2001.5263.
5
Mechanism of copper(II) inhibiting Alzheimer's amyloid beta-peptide from aggregation: a molecular dynamics investigation.铜(II)抑制阿尔茨海默病淀粉样β肽聚集的机制:分子动力学研究
J Phys Chem B. 2007 Jul 5;111(26):7646-55. doi: 10.1021/jp0673359. Epub 2007 Jun 12.
6
Zinc binding to amyloid-beta: isothermal titration calorimetry and Zn competition experiments with Zn sensors.锌与β-淀粉样蛋白的结合:等温滴定量热法及使用锌传感器的锌竞争实验
Biochemistry. 2007 Nov 27;46(47):13658-66. doi: 10.1021/bi701355j. Epub 2007 Nov 6.
7
NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.核磁共振揭示了铜(II)与阿尔茨海默病淀粉样β肽的异常结合。
J Am Chem Soc. 2006 Jul 26;128(29):9260-1. doi: 10.1021/ja046032u.
8
Characterization of copper binding to the peptide amyloid-beta(1-16) associated with Alzheimer's disease.与阿尔茨海默病相关的肽β-淀粉样蛋白(1-16)结合铜的特性研究。
Biopolymers. 2006 Sep;83(1):20-31. doi: 10.1002/bip.20523.
9
Pleomorphic copper coordination by Alzheimer's disease amyloid-beta peptide.阿尔茨海默病β淀粉样肽的多形性铜配位
J Am Chem Soc. 2009 Jan 28;131(3):1195-207. doi: 10.1021/ja808073b.
10
Amyloid-beta binds Cu2+ in a mononuclear metal ion binding site.β-淀粉样蛋白在单核金属离子结合位点结合铜离子(Cu2+)。
J Am Chem Soc. 2004 Oct 20;126(41):13534-8. doi: 10.1021/ja0488028.

引用本文的文献

1
Reevaluating the role of amyloid -peptides in Alzheimer's disease: from pathogenic agents to protective chelation mechanisms.重新评估淀粉样肽在阿尔茨海默病中的作用:从病原体到保护性螯合机制。
Front Neurol. 2025 Mar 28;16:1550709. doi: 10.3389/fneur.2025.1550709. eCollection 2025.
2
Current biomarkers and treatment strategies in Alzheimer disease: An overview and future perspectives.阿尔茨海默病的当前生物标志物与治疗策略:概述与未来展望
IBRO Neurosci Rep. 2023 Nov 30;16:8-42. doi: 10.1016/j.ibneur.2023.11.003. eCollection 2024 Jun.
3
Microglia and Astrocytes in Alzheimer's Disease in the Context of the Aberrant Copper Homeostasis Hypothesis.
小胶质细胞和星形胶质细胞在异常铜稳态假说背景下的阿尔茨海默病。
Biomolecules. 2021 Oct 28;11(11):1598. doi: 10.3390/biom11111598.
4
Cu and Zn coordination to amyloid peptides: From fascinating chemistry to debated pathological relevance.铜和锌与淀粉样肽的配位作用:从迷人的化学到存在争议的病理相关性。
Coord Chem Rev. 2018 Sep 15;375:38-55. doi: 10.1016/j.ccr.2018.04.007.
5
Effect of Copper and Zinc on the Single Molecule Self-Affinity of Alzheimer's Amyloid-β Peptides.铜和锌对阿尔茨海默病β淀粉样肽单分子自亲和力的影响。
PLoS One. 2016 Jan 25;11(1):e0147488. doi: 10.1371/journal.pone.0147488. eCollection 2016.
6
Effect of metals on kinetic pathways of amyloid-β aggregation.金属对β-淀粉样蛋白聚集动力学途径的影响。
Biomolecules. 2014 Jan 10;4(1):101-16. doi: 10.3390/biom4010101.
7
Cu(2+) affects amyloid-β (1-42) aggregation by increasing peptide-peptide binding forces.Cu(2+) 通过增加肽-肽结合力来影响淀粉样β(1-42)的聚集。
PLoS One. 2013;8(3):e59005. doi: 10.1371/journal.pone.0059005. Epub 2013 Mar 11.
8
Surface-engineered nanoliposomes by chelating ligands for modulating the neurotoxicity associated with β-amyloid aggregates of Alzheimer's disease.通过螯合配体对纳米脂质体进行表面工程改造,以调节与阿尔茨海默病β-淀粉样蛋白聚集物相关的神经毒性。
Pharm Res. 2012 Nov;29(11):3075-89. doi: 10.1007/s11095-012-0770-0. Epub 2012 May 15.
9
Polymorphism in Alzheimer Abeta amyloid organization reflects conformational selection in a rugged energy landscape.阿尔茨海默病β淀粉样蛋白组织中的多态性反映了崎岖能量景观中的构象选择。
Chem Rev. 2010 Aug 11;110(8):4820-38. doi: 10.1021/cr900377t.
10
Pharmacotherapeutic targets in Alzheimer's disease.阿尔茨海默病的药物治疗靶点
J Cell Mol Med. 2009 Jan;13(1):61-86. doi: 10.1111/j.1582-4934.2008.00595.x. Epub 2008 Nov 18.